一种基于植物蛋白多组合的强效海绵,用于凝血病性血液静止
Yu Wang1, Xin Li1,2, Hanlu Chen1
1State Key Laboratory of Chemical Resource Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, PR China.
Materials today. Bio
|August 14, 2025
概括
这项研究开发了一种用于凝海绵的新型-多联 (ZC) 涂层,可显著改善血静,即使在凝血病状况下. 这项创新提供了增强的伤口愈合和血流控制.
科学领域:
- 生物材料工程 生物材料工程
- 血液静止研究 血液静止研究
- 纳米技术应用 纳米技术应用
背景情况:
- 商业上可用的凝海绵通过缩血液成分来帮助血液静止.
- 目前的静血方法在凝血病的条件下是无效的.
- 需要先进的静血材料,可以在各种出血场景中发挥作用.
研究的目的:
- 设计和开发促凝剂和多联 (ZC) 纳米组件.
- 用 ZC 纳米组件来功能化凝海绵,以提高血静.
- 评估ZC涂层的凝海绵在体外和体内血液静止的疗效.
主要方法:
- 采用抗溶剂策略合成了-多联 (ZC) 纳米组件.
- 商用凝海绵的表面功能化使用ZC纳米组件.
- 在体外测试中评估了静血性质,包括细胞粘附.
- 在体内研究中使用了股骨动脉损伤模型来评估不同条件下的血静.
主要成果:
- 涂有 ZC 的凝海绵在体外表现出增强的静血性质.
- 在ZC涂层的海绵上观察到红细胞和血小板的较强粘附.
- 在关动脉损伤模型中,ZC增强的海绵显示出优越的静血潜力.
- 在依赖凝血和凝血病的条件下都实现了有效的血液静止.
结论:
- -多联纳米组件有效地增强了凝海绵的血静性质.
- 涂有ZC的凝海绵在各种临床环境中为控制出血提供了一个有前途的解决方案.
- 这种方法为先进的基于基因的促凝生物材料铺平了道路.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K


